Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F6ZCT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,817
Award facts
- Contract value 100% obligated
- $4,816.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,816.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhaler medication used in respiratory disease management. This is a firm fixed-price delivery order with no set-aside designation, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for defense and military healthcare systems. The company was competitively selected for this delivery order, consistent with its track record of fulfilling federal pharmaceutical supply requirements through open competition. The SPE2DX prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F6ZCT?
SPE2DR26F6ZCT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F6ZCT worth?
The government has obligated $4,817 on SPE2DR26F6ZCT.
Is contract SPE2DR26F6ZCT an order under another contract?
Yes. SPE2DR26F6ZCT is a delivery order under SPE2DR25D3803, an indefinite delivery contract.
Was contract SPE2DR26F6ZCT competed?
The extent of competition for SPE2DR26F6ZCT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award